glycine has been researched along with Atrial Fibrillation in 8 studies
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the influence of nonvalvular atrial fibrillation (NVAF) on the pharmacokinetic (PK) properties of the oral direct thrombin inhibitor ximelagatran and its active form, melagatran." | 9.10 | Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects. ( Eriksson, UG; Grind, M; Svensson, M; Wåhlander, K; Wollbratt, M; Wolzt, M, 2003) |
| "To investigate the influence of nonvalvular atrial fibrillation (NVAF) on the pharmacokinetic (PK) properties of the oral direct thrombin inhibitor ximelagatran and its active form, melagatran." | 5.10 | Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects. ( Eriksson, UG; Grind, M; Svensson, M; Wåhlander, K; Wollbratt, M; Wolzt, M, 2003) |
| "Ximelagatran has the potential to meet this need." | 2.42 | Orally active direct thrombin inhibitors. ( Weitz, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nikulina, SIu | 1 |
| Shul'man, VA | 1 |
| Kuznetsova, OO | 1 |
| Aksiutina, NV | 1 |
| Chernova, AA | 1 |
| Maksimov, VN | 1 |
| Kulikov, IV | 1 |
| Ustinov, SN | 1 |
| Kazarinova, IuL | 1 |
| Romashchenko, AG | 1 |
| Voevoda, MI | 1 |
| Abe, T | 1 |
| Usui, A | 1 |
| Oshima, H | 1 |
| Akita, T | 1 |
| Ueda, Y | 1 |
| Lin, YK | 1 |
| Lai, MS | 1 |
| Chen, YC | 1 |
| Cheng, CC | 1 |
| Huang, JH | 1 |
| Chen, SA | 1 |
| Chen, YJ | 1 |
| Lin, CI | 1 |
| Wolzt, M | 1 |
| Wollbratt, M | 1 |
| Svensson, M | 1 |
| Wåhlander, K | 1 |
| Grind, M | 1 |
| Eriksson, UG | 1 |
| Salam, AM | 1 |
| Al-Mousa, EN | 1 |
| Weitz, J | 1 |
| Yang, Y | 1 |
| Liu, Y | 1 |
| Dong, X | 1 |
| Kuang, Y | 1 |
| Lin, J | 1 |
| Su, X | 1 |
| Peng, L | 1 |
| Jin, Q | 1 |
| He, Y | 1 |
| Liu, B | 1 |
| Pan, Z | 1 |
| Li, L | 1 |
| Zhu, Q | 1 |
| Lin, X | 1 |
| Zhou, Q | 1 |
| Pan, Q | 1 |
| Eurlings, PM | 1 |
| Fei, J | 1 |
| Wang, Z | 1 |
| Chen, YH | 1 |
| Harenberg, J | 1 |
| Wehling, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Perioperative Application of Sivelestat Sodium in Acute Type A Aortic Dissection Patients With Preoperative Moderate to Severe Hypoxemia to Shorten the Duration of Postoperative Invasive Mechanical Ventilation[NCT05874700] | 30 participants (Anticipated) | Interventional | 2023-05-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for glycine and Atrial Fibrillation
| Article | Year |
|---|---|
The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials.
Topics: Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Ar | 2004 |
Orally active direct thrombin inhibitors.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Blood Coagulati | 2003 |
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benz | 2008 |
2 trials available for glycine and Atrial Fibrillation
| Article | Year |
|---|---|
A pilot randomized study of the neutrophil elastase inhibitor, Sivelestat, in patients undergoing cardiac surgery.
Topics: Aged; Atrial Fibrillation; Cardiopulmonary Bypass; Coronary Artery Bypass; Feasibility Studies; Fema | 2009 |
Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects.
Topics: Administration, Oral; Adult; Aged; Aging; Area Under Curve; Atrial Fibrillation; Azetidines; Benzyla | 2003 |
3 other studies available for glycine and Atrial Fibrillation
| Article | Year |
|---|---|
[Genetics of atrial fibrillation].
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Atrial Fibrillation; Child; Child, Preschool; Fema | 2009 |
Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Blotting, Western; Chloramphe | 2012 |
Human KCNQ1 S140G mutation is associated with atrioventricular blocks.
Topics: Animals; Atrial Fibrillation; Atrioventricular Node; China; Chromans; Electrocardiography; Female; G | 2007 |